Literature DB >> 22411914

The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.

Immacolata Andolfo1, Lucia Liguori, Pasqualino De Antonellis, Emilio Cusanelli, Federica Marinaro, Francesca Pistollato, Livia Garzia, Gennaro De Vita, Giuseppe Petrosino, Benedetta Accordi, Roberta Migliorati, Giuseppe Basso, Achille Iolascon, Giuseppe Cinalli, Massimo Zollo.   

Abstract

Micro-RNA (miR) 199b-5p targets Hes1 in medulloblastoma, one of the downstream effectors of both the canonical Notch and noncanonical Sonic Hedgehog pathways. In medulloblastoma patients, expression of miR-199b-5p is significantly decreased in metastatic cases, thus suggesting a downregulation mechanism. We studied this mechanism, which is mediated mostly by Hes1 and epigenetic promoter modifications. The miR-199b-5p promoter region was characterized, which identified a Hes1 binding site, thus demonstrating a negative feedback loop of regulation. MiR-199b-5p was shown to be downregulated in several medulloblastoma cell lines and in tumors by epigenetic methylation of a cytosine-phosphate-guanine island upstream of the miR-199b-5p promoter. Furthermore, the cluster of differention (CD) carbohydrate antigen CD15, a marker of medulloblastoma tumor-propagating cells, is an additional direct target of miR-199b-5p. Most importantly, regulation of miR-199b-5p expression in these CD15+/CD133+ tumor-propagating cells was influenced by only Hes1 expression and not by any epigenetic mechanism of regulation. Moreover, reverse-phase protein array analysis showed both the Akt and extracellular-signal-regulated kinase pathways as being mainly negatively regulated by miR-199b-5p expression in several medulloblastoma cell lines and in primary cell cultures. We present here the finely tuned regulation of miR-199b-5p in medulloblastoma, underlining its crucial role by its additional targeting of CD15.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411914      PMCID: PMC3337299          DOI: 10.1093/neuonc/nos002

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  64 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  What's new in neuro-oncology? Recent advances in medulloblastoma.

Authors:  David W Ellison; Steven C Clifford; Amar Gajjar; Richard J Gilbertson
Journal:  Eur J Paediatr Neurol       Date:  2003       Impact factor: 3.140

3.  Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.

Authors:  M C Frühwald; M S O'Dorisio; Z Dai; S M Tanner; D A Balster; X Gao; F A Wright; C Plass
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

4.  Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays.

Authors:  Julia D Wulfkuhle; Joy A Aquino; Valerie S Calvert; David A Fishman; George Coukos; Lance A Liotta; Emanuel F Petricoin
Journal:  Proteomics       Date:  2003-11       Impact factor: 3.984

Review 5.  Protein microarrays: molecular profiling technologies for clinical specimens.

Authors:  Virginia Espina; Arpita I Mehta; Mary E Winters; Valerie Calvert; Julia Wulfkuhle; Emanuel F Petricoin; Lance A Liotta
Journal:  Proteomics       Date:  2003-11       Impact factor: 3.984

Review 6.  Classifying the medulloblastoma: insights from morphology and molecular genetics.

Authors:  D Ellison
Journal:  Neuropathol Appl Neurobiol       Date:  2002-08       Impact factor: 8.090

Review 7.  The origins of medulloblastoma subtypes.

Authors:  Richard J Gilbertson; David W Ellison
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma.

Authors:  Jessica Pierson; Bruce Hostager; Rong Fan; Rajeev Vibhakar
Journal:  J Neurooncol       Date:  2008-07-08       Impact factor: 4.130

9.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.

Authors:  Yuan Lu; Sarra L Ryan; David J Elliott; Graham R Bignell; P Andrew Futreal; David W Ellison; Simon Bailey; Steven C Clifford
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more
  30 in total

1.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

2.  MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines.

Authors:  Pasqualino de Antonellis; Lucia Liguori; Annarita Falanga; Marianeve Carotenuto; Veronica Ferrucci; Immacolata Andolfo; Federica Marinaro; Immacolata Scognamiglio; Antonella Virgilio; Giuseppe De Rosa; Aldo Galeone; Stefania Galdiero; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-26       Impact factor: 3.000

3.  Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.

Authors:  Haibin Zeng; Zhong Zhang; Xiaoming Dai; Yongzhong Chen; Jianhua Ye; Zhixin Jin
Journal:  Pathol Oncol Res       Date:  2015-06-18       Impact factor: 3.201

4.  CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population.

Authors:  Emma Kenney-Herbert; Talal Al-Mayhani; Sara G M Piccirillo; Joanna Fowler; Inmaculada Spiteri; Philip Jones; Colin Watts
Journal:  Stem Cells Transl Med       Date:  2015-05-27       Impact factor: 6.940

5.  Insights into miRNA regulation of the human glycome.

Authors:  Brian T Kasper; Sujeethraj Koppolu; Lara K Mahal
Journal:  Biochem Biophys Res Commun       Date:  2014-01-23       Impact factor: 3.575

Review 6.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

7.  Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode.

Authors:  Praveen Agrawal; Tomasz Kurcon; Kanoelani T Pilobello; John F Rakus; Sujeethraj Koppolu; Zhongyin Liu; Bianca S Batista; William S Eng; Ku-Lung Hsu; Yaxuan Liang; Lara K Mahal
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

8.  miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.

Authors:  Yulin Lai; Jing Quan; Canbin Lin; Hang Li; Jia Hu; Peijie Chen; Jinling Xu; Xin Guan; Weijie Xu; Yongqing Lai; Liangchao Ni
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

Review 9.  miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Authors:  Xin Wang; Borja L Holgado; Vijay Ramaswamy; Stephen Mack; Kory Zayne; Marc Remke; Xiaochong Wu; Livia Garzia; Craig Daniels; Anna M Kenney; Michael D Taylor
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

10.  MiR199b suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in prostate cancer cells.

Authors:  Weiwei Shang; Xueqin Chen; Ling Nie; Miao Xu; Ni Chen; Hao Zeng; Qiao Zhou
Journal:  Int J Mol Sci       Date:  2013-04-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.